期刊文献+

姜黄素衍生物C1209抑制慢性粒细胞白血病细胞增殖与阻断Hsp90伴侣功能的关系 被引量:5

Inhibition of curcumin derivative C1209 on proliferation of CML cells by disrupting Hsp90 chaperon function
下载PDF
导出
摘要 目的研究姜黄素衍生物C1209抑制慢性粒细胞白血病细胞增殖与阻断Hsp90伴侣功能的关系。方法采用荧光光谱法,研究不同浓度C1209与Hsp90、其N端片段(NHsp90)、M端片段(MHsp90)、C端片段(CHsp90)的相互作用,以及不同温度(293 K、303 K、310 K)下,C1209与Hsp90的相互作用;实验选取280 nm为激发波长,290~510 nm的波长范围内进行荧光光谱扫描。采用孔雀绿磷钼酸铵-无机磷检测法,研究C1209对Hsp90-ATPase活性的抑制。四甲基偶氮唑蓝(MTT)法和羟基荧光素二醋酸盐琥珀酰亚胺脂(CFSE)染色法体外检测C1209对白血病细胞K562及耐伊马替尼(IM)的白血病细胞K562/G01细胞的增殖抑制作用;应用蛋白免疫印迹法检测Hsp90客户蛋白及其下游蛋白、Hsp90分子伴侣的表达。结果C1209解离常数为(14.733±0.713)μmol·L^(-1);C1209与Hsp90之间的主要作用力为静电作用力;C1209与Hsp90的C端片段结合能力最强。当ATP为1 mmol·L^(-1)时,C1209作用于Hsp90的IC50值为11.4μmol·L^(-1)。C1209呈剂量依赖性地抑制K562和K562/G01细胞的增殖,作用24 h的IC50为1.14μmol·L^(-1)和0.56μmol·L^(-1);C1209影响Hsp90的分子伴侣功能,且下调K562和K562/G01细胞中Bcr-Abl、Akt、MEK、ERK、c-Raf及其相应磷酸化蛋白p-Akt、p-MEK、p-ERK等Hsp90客户蛋白及其下游蛋白的表达。结论姜黄素衍生物C1209是Hsp90抑制剂,对K562和耐IM的白血病细胞K562/G01具有明显的增殖抑制作用,可能与其抑制Hsp90的分子伴侣功能、下调Hsp90客户蛋白有关。 Aim To estimate the inhibition of curcumin derivative C1209 on the proliferation of chronic myeloid leukemia( CML) cells involving the disruption Hsp90 chaperon function. Methods The fluorescence spectrum experiment was applied to examine the affinity between different C1209 concentrations and Hsp90,NHsp90,MHsp90,CHsp90; fluorescence intensities were recorded in the range of 290 ~ 510 nm at 293 K,303 K and 310 K,respectively; a colorimetric assay for inorganic phosphate based on the formation of a phosphomolybdate complex and subsequent reaction with malachite green was used to examine the inhibitory effects of C1209 on the activity of Hsp90 ATPase. MTT assay and CFSE were used for K562 and K562/G01 cell proliferation determination in vitro by C1209. Western blot was used to detect the client proteins and the molecular chaperone of Hsp90 level. Results The dissociation constant KDvalues of C1209 was( 14. 733 ±0. 713) μmol · L-1. The interaction between C1209 and Hsp90 was driven mainly by electrostatic interaction. C1209 showed the strongest affinity with CHsp90. When the concentration of ATP was 1 mmol·L-1,the inhibition of Hsp90 ATPase activity of C1209 with the IC50 value was 11. 4 μmol · L-1; C1209 showed inhibition of K562 and K562/G01 cells in dosedependent proliferation and the IC50 value was 1. 14μmol · L-1 and 0. 56 μmol · L-1,respectively after24 h incubation. C1209 affected the molecular chaperone functions of Hsp90 and down-regulated Bcr-Abl,Akt,MEK,ERK,c-Raf,p-Akt,p-MEK and p-ERK protein levels which were client proteins of Hsp90 in K562 and K562/G01 cells. Conclusions Curcumin derivative C1209 is Hsp90 inhibitor; C1209 has significant inhibitory effects on proliferation of K562 and K562/G01,which may be related to C1209 affecting the molecular chaperone functions of Hsp90 and downregulating client proteins of Hsp90 level.
出处 《中国药理学通报》 CAS CSCD 北大核心 2018年第3期393-400,共8页 Chinese Pharmacological Bulletin
基金 福建省自然科学基金资助项目(No 2017J01821) 福建省卫计委青年项目(No 2015-1-72) 国家自然科学基金资助项目(No 81173096) 国家科技部"重大新药创制"科技重大专项(No 2012ZX09103-101-028) 福建省高校产学合作项目(No 2016Y4005)
关键词 C1209 HSP90 ATPASE活性 荧光光谱法 相互作用 抑制作用 C1209 Hsp90 ATPase activity fluorescence spectrometry interaction inhibition
  • 相关文献

参考文献7

二级参考文献42

  • 1罗红霞,邓华瑜,郑维萍.HSP90的抑制剂Geldanamycin对乳腺癌细胞侵袭、转移能力的影响[J].重庆医科大学学报,2006,31(1):55-57. 被引量:2
  • 2王绯,杨永平.HSP90抑制剂靶向治疗癌症研究进展[J].解放军医学杂志,2006,31(3):274-275. 被引量:6
  • 3Li-xian WU,Jian-hua XU,Xiu-wang HUANG,Kun-zhong ZHANG,Cai-xia WEN,Yuan-zhong CHEN.Down-regulation of p210^(bcr/abl)by curcumin involves disrupting molecular chaperone functions of Hsp90[J].Acta Pharmacologica Sinica,2006,27(6):694-699. 被引量:10
  • 4王若宇,黄耀坚,郑忠辉,苏文金,沈月毛.海洋真菌Diaporthe sp.产真菌环氧二烯发酵条件的优化[J].微生物学通报,2006,33(5):6-11. 被引量:6
  • 5Wu W C,Kao Y H,Hu P S,et al.Geldanamycin,a Hsp90 inhibitor,attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro[J].Exp Eye Res,2007,85(5):721-731.
  • 6Chen B,Zhong D,Monteiro A.Comparative genomics and evolution of the Hsp90 family of genes across all kingdoms of organisms[J].BMC Genomics,2006,7:156.
  • 7Taldone T,Gozman A,Maharaj R,et al.Targeting Hsp-90:small-molecule inhibitors and their clinical development[J].Curr Opin Pharmacol,2008,8(4):370-374.
  • 8Li Y,Zhang T,Schwartz S J,et al.New developments in Hsp90 inhibitors as anti-cancer therapeutics:mechanisms,clinical perspective and more potential[J].Drug Resist Updat,2009,12(1/2):17-27.
  • 9Georgakis G V,Li Y,Rassidakis G Z,et al.The Hsp90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression[J].Exp Hematol,2006,34(12):1670-1679.
  • 10Muranaka K,Sano A,Ichikawa S,et al.Synthesis of H-sp90 inhibitor dimers as potential antitumor agents[J].Bioorg Med Chem,2008,16(11):5862-5870.

共引文献18

同被引文献43

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部